Stay updated on Ipilimumab Nivolumab Combo in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Ipilimumab Nivolumab Combo in Melanoma Clinical Trial page.

Latest updates to the Ipilimumab Nivolumab Combo in Melanoma Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedAdded Revision: v3.4.2; removed the government funding operating-status banner. Core study content, including eligibility criteria, interventions, and outcomes, remains unchanged.SummaryDifference0.4%

- Check25 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and current operating status. Updated the page revision to v3.4.1, replacing v3.4.0.SummaryDifference0.4%

- Check33 days agoChange DetectedUI/metadata updates include adding glossary display, melanoma as a related topic, MedlinePlus Genetics, and a new revision tag (v3.4.0), replacing older QC-related labels. The old labels Last Update Submitted that met QC Criteria, No FEAR Act data, and v3.3.4 were removed.SummaryDifference0.4%

- Check47 days agoChange DetectedThe page shows a revision banner updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check54 days agoChange DetectedAdded Melanoma as a related topic and MedlinePlus Genetics as related topics. These metadata updates enhance discoverability and context without altering the study content or eligibility criteria.SummaryDifference0.2%

- Check61 days agoChange DetectedRemoved related topics links for Melanoma and MedlinePlus Genetics; these are supplementary resources and do not alter the main study information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Ipilimumab Nivolumab Combo in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipilimumab Nivolumab Combo in Melanoma Clinical Trial page.